StockData
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. (VKTX) KPIs and segments

VKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/30
$26.88+0.08 (+0.30%)

Close on Nov 17, 2026Market cap $3.43BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Viking Therapeutics's business

Coming soon

This tab will track the numbers specific to Viking Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?